Improved outcomes in metastatic germ cell cancer: results from a large cohort study

PURPOSE: Treatment of metastatic germ cell cancer (GCC) is based on the International Germ Cell Cancer Collaborative Group (IGCCCG) prognostic classification published in 1997. 5-year survival rates were reported to be 91%, 79%, and 48% for patients with good, intermediate and poor prognosis, respec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentrich, Marcus, Debole, Jessica, Jurinovic, Vindi, Gerl, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817577/
https://www.ncbi.nlm.nih.gov/pubmed/32772232
http://dx.doi.org/10.1007/s00432-020-03343-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817577/
https://www.ncbi.nlm.nih.gov/pubmed/32772232
http://dx.doi.org/10.1007/s00432-020-03343-2

Ejemplares similares